Important Safety Information re: Potassium Chloride for Injection

To address a current shortage, B.Braun Medical Inc is coordinating with the US FDA to release five lots of potassium chloride for injection USP 500 mEq/250 mL pharmacy bulk package that contain lead concentrations that exceed the upper limit of 25 mcg/L established by the FDA-approved drug application. While a Health Hazard Analysis has been conducted that concluded that the presence of up to 4 mcg/L more of lead in this product does not represent a significant increase in risks to human health if prescribed in accordance to product labeling, sensitivity to lead toxicity is greater in certain populations, such as pediatric patients. Please see this Important Drug Warning from B. Braun for additional detail.